MarginsXMarginsX
Home › Markets › Industrials › BIO

Bio-Rad Laboratories Inc. (BIO)

BIO trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$360.26
-1.67% on the day
Market cap
$9.7B
Mid cap
Revenue · 2025
$2.6B
+0.7% on 2024
Net income · 2025
$759.9M
29.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/12208/000001220826000010/0000012208-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBIO on NYSE
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year1980
SEC CIK0000012208
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.6B
Net income$759.9M
Operating income$47.2M
Net margin29.4%
Operating margin1.8%
Revenue growth+0.7%
Cash$529.8M
Total assets$10.6B
P/E (computed)12.7×
P/S (computed)3.8×

Warning signs

Cash runway
Cash-flow positive
$465.3M cash at September 30, 2026
Share count, 1 year
-0.3%
2025-10-31 to 2026-10-30
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$350K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$465.3M cash; operating cash flow $117.0M a quarter.Report 2026-09-30
Shares outstanding26,892,945 (2026-10-30); 26,974,835 a year earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Santa Clara, California, United StatesPCAOB Form AP 2026-03-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $350K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$656.4M$458.6M$96.4M$465.3M$1.2B$2.6B10-Q 2026-11-04
Q2 2026
2026-06-30
$651.0M$371.4M$98.7M$517.0M$1.2B$2.6B10-Q 2026-08-04
Q1 2026
2026-03-31
$592.1M-$527.1M$108.1M$507.2M$1.2B$2.6B10-Q 2026-04-30
Q4 2025
2025-12-31
$693.2M$720.0M$164.9M$529.8M$1.2B$2.6B10-K 2026-02-13
Q3 2025
2025-09-30
$653.0M-$341.9M$120.9M$395.8M$1.2B$2.6B10-Q 2026-11-04
Q2 2025
2025-06-30
$651.6M$317.8M$116.5M$369.3M$1.2B$2.6B10-Q 2026-08-04
Q1 2025
2025-03-31
$585.4M$64.0M$129.9M$521.4M$1.2B$2.5B10-Q 2026-04-30
Q4 2024
2024-12-31
$667.5M-$715.8M$124.2M$488.1M$1.2B$2.6B10-K 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22022-02-25
Latest annual report10-K2026-02-13
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxy
DEFINITIVE PROXY STATEMENT
DEF 14A2026-03-25

Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.0%
1 month+0.7%
3 months+1.4%
Year to date+20.9%
1 year+15.6%
From 52-week high-6.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
BIO/BBio-Rad Laboratories Inc.$377.29

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
BRKRBruker Corporation$60.62-1.57%$9.3B
AVTRAvantor Inc.$15.32-1.42%$10.4B
TXG10x Genomics Inc.$54.99-5.50%$7.2B
RVTYRevvity Inc.$148.85-3.59%$16.6B
MTDMettler-Toledo International Inc.$1727.26-0.67%$34.4B
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B
WATWaters Corporation$453.42-1.48%$44.6B
AAgilent Technologies Inc.$172.92-0.60%$48.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier